M. Snee
Publications by Year
Research Areas
Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Pleural and Pulmonary Diseases, Advanced Radiotherapy Techniques
Most-Cited Works
- → Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer(2007)1,112 cited
- → Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study(2011)708 cited
- → Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial(2017)553 cited
- → Guidelines on the radical management of patients with lung cancer(2010)535 cited
- → Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial(2008)257 cited
- → Prophylactic Cranial Irradiation in Extensive Disease Small-Cell Lung Cancer: Short-Term Health-Related Quality of Life and Patient Reported Symptoms—Results of an International Phase III Randomized Controlled Trial by the EORTC Radiation Oncology and Lung Cancer Groups(2008)250 cited
- → SOCCAR: A randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III Non-Small Cell Lung Cancer and good performance status(2014)128 cited
- → The Mesothelioma and Radical Surgery Randomized Controlled Trial: The MARS Feasibility Study(2009)81 cited
- → Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial(2019)65 cited
- → A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1)(2006)64 cited